SCHEMBL1907944

SCHEMBL1907944

O=C(O)NC1CN(Cc2ccccc2)C1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.55
S1PR5 Q9H228 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
DRD4 P21917 5/20 0.55
DRD2 P14416 4/20 0.55
DRD3 P35462 1/20 0.55
KMT2A Q03164 1/20 0.55
FUCA1 P04066 2/20 0.54
DPP7 Q9UHL4 1/20 0.54
FAAH O00519 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
POLB P06746 1/20 0.51
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
BACE1 P56817 1/20 0.50
KDM4E B2RXH2 1/20 0.50
MAPT P10636 1/20 0.50
MC4R P32245 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17294922 0.93 S1PR1 (0.53) S1PR1S1PR5SIGMAR1DRD4DRD2
SCHEMBL22399618 0.88 FUCA1 (0.50) S1PR1S1PR5SIGMAR1DRD4DRD2
SCHEMBL17961749 0.87 DRD4 (0.70) SIGMAR1DRD4DRD2DRD3KMT2A
SCHEMBL20183285 0.87 DRD4 (0.70) SIGMAR1DRD4DRD2DRD3KMT2A
SCHEMBL19614234 0.87 DRD4 (0.70) SIGMAR1DRD4DRD2DRD3KMT2A
SCHEMBL12655772 0.87 S1PR1 (0.53) S1PR1S1PR5SIGMAR1DRD4DRD2
SCHEMBL25265214 0.87 HRH4 (0.49) S1PR1S1PR5SIGMAR1DRD4DRD2
SCHEMBL16653708 0.87 HRH4 (0.49) S1PR1S1PR5SIGMAR1DRD4DRD2
SCHEMBL15880136 0.87 HRH4 (0.49) S1PR1S1PR5SIGMAR1DRD4DRD2
SCHEMBL15914140 0.87 HRH4 (0.49) S1PR1S1PR5SIGMAR1DRD4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117242060-A Isoindolinone compounds 蒙特罗萨医疗公司 2023-12-15 CN disclosed
WO-2011060397-A1 SUBSTITUTED AMINO HETEROCYCLES USEFUL AS HIV ANTAGONISTS SCHERING CORPORATION (US) 2011-05-19 WO disclosed